Cargando…
Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874379/ https://www.ncbi.nlm.nih.gov/pubmed/29610614 http://dx.doi.org/10.3889/oamjms.2018.133 |
_version_ | 1783310155657510912 |
---|---|
author | Pancevski, Goran Pepic, Senada Idoska, Sanela Tofoski, Gligor Nikolovska, Suzana |
author_facet | Pancevski, Goran Pepic, Senada Idoska, Sanela Tofoski, Gligor Nikolovska, Suzana |
author_sort | Pancevski, Goran |
collection | PubMed |
description | BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising from the upper lip of a young male patient. These two features are in contrast to most of the reported cases in elder male individuals and on the lower lip. Relevant management protocol of the case has also been discussed. CONCLUSION: The article emphasises the significance of discerning such lesions from squamous cell carcinoma thus carrying diagnostic and therapeutic implications. However, in case of the dilemma it is prudent to assume that the lesion is SCC unless proved otherwise clinically and histologically. |
format | Online Article Text |
id | pubmed-5874379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Republic of Macedonia |
record_format | MEDLINE/PubMed |
spelling | pubmed-58743792018-04-02 Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma Pancevski, Goran Pepic, Senada Idoska, Sanela Tofoski, Gligor Nikolovska, Suzana Open Access Maced J Med Sci Case Report BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising from the upper lip of a young male patient. These two features are in contrast to most of the reported cases in elder male individuals and on the lower lip. Relevant management protocol of the case has also been discussed. CONCLUSION: The article emphasises the significance of discerning such lesions from squamous cell carcinoma thus carrying diagnostic and therapeutic implications. However, in case of the dilemma it is prudent to assume that the lesion is SCC unless proved otherwise clinically and histologically. Republic of Macedonia 2018-03-08 /pmc/articles/PMC5874379/ /pubmed/29610614 http://dx.doi.org/10.3889/oamjms.2018.133 Text en Copyright: © 2018 Brikene Elshani, Heroid Arifi, Armond Daci. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
spellingShingle | Case Report Pancevski, Goran Pepic, Senada Idoska, Sanela Tofoski, Gligor Nikolovska, Suzana Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title | Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title_full | Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title_fullStr | Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title_full_unstemmed | Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title_short | Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma |
title_sort | topical imiquimod 5% as a treatment option in solitary facial keratoacanthoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874379/ https://www.ncbi.nlm.nih.gov/pubmed/29610614 http://dx.doi.org/10.3889/oamjms.2018.133 |
work_keys_str_mv | AT pancevskigoran topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma AT pepicsenada topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma AT idoskasanela topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma AT tofoskigligor topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma AT nikolovskasuzana topicalimiquimod5asatreatmentoptioninsolitaryfacialkeratoacanthoma |